New COVID-19 strain: More than 22 passengers flying from the United Kingdom to India have tested positive for Coronavirus Amid the alarming concerns over a new COVID-19 strain, at least 22 people who came to India from the United Kingdom over the past few days have tested positive for the disease.  As per media reports, ...

Covaxin phase 1 trials: Results of phase 1 trials of Covaxin vaccine were released in a preprint paper “A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine -BBV152”. Preprint paper is a scientific manuscript version which is posted on public server before formal peer review.  The vaccine’s results propose the Covid-19 vaccine ...

Serosurvey: By Friday morning India had crossed 93 lakh mark of Covid-19 cases and added 43,082 new cases in 24 hours. Death tally reached 1,35,715 with 492 new fatalities being added. Recovered patients have reached 87.18 lakh tally.  ICMR (Indian Council of Medical Research) conducted a second national serosurvey that shows over 70% of Indian ...

Phase III clinical trials: Hyderabad based pharma giant, Bharat Biotech has announced of beginning phase III clinical trials of India’s first indigenous Covid-19 vaccine, COVAXIN. This phase will include 26,000 volunteers across 25 centres in India and is to be conducted in collaboration with the ICMR (Indian Council of Medical Research). This will make COVAXIN ...

A highly anticipated Covid-19 vaccine, COVAXIN, is being developed by Hyderabad-based Bharat Biotech in collaboration with ICMR (Indian Council of Medical Research). ICMR officials have said that the vaccine that was earlier being projected to launch only be second quarter of 2021, can now be hoped to be launched as early as February.  This is ...

Amid the ongoing efforts to combat the novel Coronavirus pandemic in the country, the Indian Council of Medical Research (ICMR) on Tuesday said that a person can get reinfected with COVID-19 if antibodies against the virus reduce in their body within five months after recovering from the disease. In line with this development, ICMR Director-General ...

Phase 1 human clinical trial for an antisera has been permitted by the Drugs Controller General of India (DCGI). The ‘antisera’ was developed by injecting inactivated SARS-CoV-2 virus in horses, and is believed to be a potential Covid-19 treatment, as relayed by ICMR officials. ICMR (Indian Council of Medical Research) has developed the antisera in ...

On Monday Union Health Minister Dr. Harsh Vardhan said that India’s first vaccine for Covid-19 is likely to be roll out for public use in first quarter of 2021. Dr. Vardhan said, “Research to develop vaccine is being done expeditiously. There are at least three viable such vaccine candidates that are in the phase of ...

Union Health Minister Dr Harsh Vardhan on Sunday stated that the Indian population is still far from achieving herd immunity against COVID-19 as indicated by early findings of the second Sero survey conducted by the Indian Council of Medical Research (ICMR) across the country. “The findings of the second sero survey are going to be ...

The Indian Council of Medical Research (ICMR) has allowed ‘testing on demand’ under new Covid-19 testing strategy. The guideline has however been left to states for modification on their discretion. ICMR has advised “testing on demand for all individuals undertaking travel to countries or Indian states mandating a negative Covid-19 test at the point of ...